Dan Dearborn

Dan Dearborn

Chief Financial OfficeratTuHURA Biosciences, Inc./NV· In proxies 2024–2025

Pay in FY2025-37% from the year before · TuHURA Biosciences, Inc./NV stock -81.5% the same year

Dan Dearborn was paid $1.8M in FY2025 (Dec), down 37%. TuHURA Biosciences, Inc./NV stock fell 81.5% that year.

Pay$100 in the stock at the end of FY23 → $13
Pay is from the Summary Compensation Table of each TuHURA Biosciences, Inc./NV proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TuHURA Biosciences, Inc./NVPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?